Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Triebel

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|June 11, 1997
T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccinesF Farace, E Angevin, I Poullion, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Generation of monocyte-derived dendritic cells from patients with renal cell cancer: modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12)M Merad, E Angevin, J Wolfers, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancerE Angevin, D Valteau-Couanet, F Farace, et al.
Cancer Research|September 1, 1992
Analysis of T-cell receptor alpha/beta variability in lymphocytes infiltrating a melanoma metastasisL Ferradini, S Roman-Roman, J Azocar, et al.
The Journal of Experimental Medicine|September 1, 1986
Sequences and diversity of human T cell receptor beta chain variable region genesN Kimura, B Toyonaga, Y Yoshikai, et al.
International Immunology|October 1, 1994
Influence of human leukocyte antigen genes on TCR V gene segment frequenciesC Genevée, F Farace, V Chung, et al.
Experimental Hematology|July 1, 1979
Trochanter bone marrow: a source of normal human colony forming cellsP G de Laforest, B Rio, F Triebel, et al.
European Cytokine Network|August 1, 1990
In vivo activation of LAK cells during systemic IL-2 therapyP Lang, I Vitté-Mony, F Farace, et al.
European Journal of Immunology|April 1, 1991
Molecular characterization of human T cell receptor alpha chains including a V delta 1-encoded variable segmentC Miossec, A Caignard, L Ferradini, et al.
International Journal of Cancer|July 9, 1993
Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinomaF Farace, E Angevin, B Escudier, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|June 11, 1997
T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccinesF Farace, E Angevin, I Poullion, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Generation of monocyte-derived dendritic cells from patients with renal cell cancer: modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12)M Merad, E Angevin, J Wolfers, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancerE Angevin, D Valteau-Couanet, F Farace, et al.
Cancer Research|September 1, 1992
Analysis of T-cell receptor alpha/beta variability in lymphocytes infiltrating a melanoma metastasisL Ferradini, S Roman-Roman, J Azocar, et al.
The Journal of Experimental Medicine|September 1, 1986
Sequences and diversity of human T cell receptor beta chain variable region genesN Kimura, B Toyonaga, Y Yoshikai, et al.
International Immunology|October 1, 1994
Influence of human leukocyte antigen genes on TCR V gene segment frequenciesC Genevée, F Farace, V Chung, et al.
Experimental Hematology|July 1, 1979
Trochanter bone marrow: a source of normal human colony forming cellsP G de Laforest, B Rio, F Triebel, et al.
European Cytokine Network|August 1, 1990
In vivo activation of LAK cells during systemic IL-2 therapyP Lang, I Vitté-Mony, F Farace, et al.
European Journal of Immunology|April 1, 1991
Molecular characterization of human T cell receptor alpha chains including a V delta 1-encoded variable segmentC Miossec, A Caignard, L Ferradini, et al.
International Journal of Cancer|July 9, 1993
Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinomaF Farace, E Angevin, B Escudier, et al.
Pageof 12